English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 16 Help

Selected(0)Clear Items/Page:    Sort:
A Novel Tetramethylpyrazine Derivative Prophylactically Protects against Glutamate-Induced Excitotoxicity in Primary Neurons through the Blockage of N-Methyl-D-aspartate Receptor Journal article
Hu, Shengquan, Hu, Huihui, Mak, Shinghung, Cui, Guozhen, Lee, Mingyuen, Shan, Luchen, Wang, Yuqiang, Lin, Huangquan, Zhang, Zaijun, Han, Yifan. A Novel Tetramethylpyrazine Derivative Prophylactically Protects against Glutamate-Induced Excitotoxicity in Primary Neurons through the Blockage of N-Methyl-D-aspartate Receptor[J]. FRONTIERS IN PHARMACOLOGY, 2018, 9.
Authors:  Hu, Shengquan;  Hu, Huihui;  Mak, Shinghung;  Cui, Guozhen;  Lee, Mingyuen; et al.
Favorite | TC[WOS]:17 TC[Scopus]:19  IF:4.4/5.0 | Submit date：2018/10/30
Alzheimer's Disease  Tetramethylpyrazine Derivative  Nmda Receptor  Neuroprotection  Oxidative Stress  Gsk3 Beta  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
Liu, Kunmeng, Lin, Hui-Heng, Pi, Rongbiao, Mak, Shinghung, Han, Yifan, Hu, Yuanjia. Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2018, 28(4), 341-350.
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan; et al.
Favorite | TC[WOS]:10 TC[Scopus]:11  IF:5.4/6.4 | Submit date：2018/10/31
Alzheimer's Disease  Patent  Technology Flow  Citation Network  Research And Development  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
Liu, Kunmeng, Lin, Hui-Heng, Pi, Rongbiao, Mak, Shinghung, Han, Yifan, Hu, Yuanjia. Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2018, 28(4), 341-350.
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan; et al.
Favorite | TC[WOS]:10 TC[Scopus]:11  IF:5.4/6.4 | Submit date：2018/10/30
Alzheimer's Disease  Patent  Technology Flow  Citation Network  Research And Development  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
Liu, Kunmeng, Lin, Hui-Heng, Pi, Rongbiao, Mak, Shinghung, Han, Yifan, Hu, Yuanjia. Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2018, 28(4), 341-350.
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan; et al.
Favorite | TC[WOS]:10 TC[Scopus]:11  IF:5.4/6.4 | Submit date：2018/10/31
Alzheimer's Disease  Patent  Technology Flow  Citation Network  Research And Development  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
Liu, Kunmeng, Lin, Hui-Heng, Pi, Rongbiao, Mak, Shinghung, Han, Yifan, Hu, Yuanjia. Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2018, 28(4), 341-350.
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan; et al.
Favorite | TC[WOS]:10 TC[Scopus]:11  IF:5.4/6.4 | Submit date：2018/10/30
Alzheimer's Disease  Patent  Technology Flow  Citation Network  Research And Development  
Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B Journal article
Guo, Baojian, Hu, Shengquan, Zheng, Chengyou, Wang, Hongyu, Luo, Fangcheng, Li, Haitao, Cui, Wei, Yang, Xifei, Cui, Guozhen, Mak, Shinghung, Choi, Tony Chung-Lit, Ma, Edmond Dik-Lung, Wang, Yuqiang, Lee, Simon Ming Yuen, Zhang, Zaijun, Han, Yifan. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B[J]. NEUROPHARMACOLOGY, 2017, 126, 12-24.
Authors:  Guo, Baojian;  Hu, Shengquan;  Zheng, Chengyou;  Wang, Hongyu;  Luo, Fangcheng; et al.
View | Adobe PDF | Favorite | TC[WOS]:18 TC[Scopus]:20  IF:4.6/4.5 | Submit date：2018/10/31
Parkinson's Disease  Su4312  Neuroprotection  Myocyte Enhancer Factor 2d  Monoamine Oxidase-b  
Indirubin-3-Oxime Prevents H2O2-Induced Neuronal Apoptosis via Concurrently Inhibiting GSK3 beta and the ERK Pathway Journal article
Yu, Jie, Zheng, Jiacheng, Lin, Jiajia, Jin, Linlu, Yu, Rui, Mak, Shinghung, Hu, Shengquan, Sun, Hongya, Wu, Xiang, Zhang, Zaijun, Lee, Mingyuen, Tsim, Wahkeung, Su, Wei, Zhou, Wenhua, Cui, Wei, Han, Yifan, Wang, Qinwen. Indirubin-3-Oxime Prevents H2O2-Induced Neuronal Apoptosis via Concurrently Inhibiting GSK3 beta and the ERK Pathway[J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2017, 37(4), 655-664.
Authors:  Yu, Jie;  Zheng, Jiacheng;  Lin, Jiajia;  Jin, Linlu;  Yu, Rui; et al.
Favorite | TC[WOS]:20 TC[Scopus]:23  IF:3.6/4.2 | Submit date：2018/10/30
Indirubin-3-oxime  H2o2  Gsk3 Beta  Pi3-k  Erk  
Potent Protection Against MPP+-Induced Neurotoxicity via Activating Transcription Factor MEF2D by a Novel Derivative of Naturally Occurring Danshensu/Tetramethylpyrazine Journal article
Hu, Shengquan, Wang, Liang, Mak, Shinghung, Zhang, Zaijun, Xu, Daping, Li, Haitao, Li, Yide, Hu, Yuanjia, Lee, Simon Ming Yuen, Wang, Yuqiang, Han, Yifan. Potent Protection Against MPP+-Induced Neurotoxicity via Activating Transcription Factor MEF2D by a Novel Derivative of Naturally Occurring Danshensu/Tetramethylpyrazine[J]. NEUROMOLECULAR MEDICINE, 2016.
Authors:  Hu, Shengquan;  Wang, Liang;  Mak, Shinghung;  Zhang, Zaijun;  Xu, Daping; et al.
Favorite | TC[WOS]:9 TC[Scopus]:9  IF:3.3/3.6 | Submit date：2022/08/31
Potent Protection Against MPP+ -Induced Neurotoxicity via Activating Transcription Factor MEF2D by a Novel Derivative of Naturally Occurring Danshensu/Tetramethylpyrazine Journal article
Shengquan Hu, Liang Wang, Shinghung Mak, Zaijun Zhang, Daping Xu, Haitao Li, Yide Li, Yuanjia Hu, Simon Ming Yuen Lee, Yuqiang Wang, Yifan Han. Potent Protection Against MPP+ -Induced Neurotoxicity via Activating Transcription Factor MEF2D by a Novel Derivative of Naturally Occurring Danshensu/Tetramethylpyrazine[J]. NEUROMOLECULAR MEDICINE, 2016, 18(4), 561-572.
Authors:  Shengquan Hu;  Liang Wang;  Shinghung Mak;  Zaijun Zhang;  Daping Xu; et al.
Favorite | TC[WOS]:9 TC[Scopus]:9  IF:3.3/3.6 | Submit date：2020/01/16
Parkinson’s Disease  Mef2d  Neuroprotection  
Substantial Neuroprotective and Neurite Outgrowth-Promoting Activities by Bis(propyl)-cognitin via the Activation of Alpha7-nAChR, a Promising Anti-Alzheimer's Dimer Journal article
Shengquan Hu, Wei Cui, Shinghung Mak, Daping Xu, Yuanjia Hu, Jing Tang, Chunglit Choi, Mingyuen Lee, Yuanping Pang, Yifan Han. Substantial Neuroprotective and Neurite Outgrowth-Promoting Activities by Bis(propyl)-cognitin via the Activation of Alpha7-nAChR, a Promising Anti-Alzheimer's Dimer[J]. ACS Chemical Neuroscience, 2015, 6(9), 1536-1545.
Authors:  Shengquan Hu;  Wei Cui;  Shinghung Mak;  Daping Xu;  Yuanjia Hu; et al.
Favorite | TC[WOS]:21 TC[Scopus]:21  IF:4.1/4.3 | Submit date：2018/11/06
Alpha7-nicotinic Acetylcholine Receptor  Alzheimer's Disease  Bis(Propyl)-cognitin  Extracellular Signal-regulated Kinase  Neurite Outgrowth  Neuroprotection